142 related articles for article (PubMed ID: 37257242)
1. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
[TBL] [Abstract][Full Text] [Related]
2. TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma.
Yang Y; Zuo S; Li W; Di M; Liu J; Chai J; Wang J; Yuan Y; Li M; Jia Q
Pathol Res Pract; 2023 Aug; 248():154710. PubMed ID: 37494805
[TBL] [Abstract][Full Text] [Related]
3. ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma.
Jia Q; Song J; Xu T; Liu J; Chai J; Yang Y; Li L; Li M; Yang X
Pathol Res Pract; 2023 Jan; 241():154268. PubMed ID: 36495760
[TBL] [Abstract][Full Text] [Related]
4. UCHL1 promotes cancer stemness in triple-negative breast cancer.
Tian C; Liu Y; Liu Y; Hu P; Xie S; Guo Y; Wang H; Zhang Z; Du L; Lei B; Wang Y; Xue L; Zhang D; Su J; Zhang X; Zhang R; Chen J; Zhang X; Chen L; Li M; Jia Q; Song J; Liu J
Pathol Res Pract; 2022 Dec; 240():154235. PubMed ID: 36434856
[TBL] [Abstract][Full Text] [Related]
5. BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
Song J; Xu F; An L; Yin Y; Liu J; Chai J; Yang Y; Li M; Jia Q; Wang Z
Pathol Res Pract; 2023 Jul; 247():154577. PubMed ID: 37257243
[TBL] [Abstract][Full Text] [Related]
6. FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma.
Yang Y; Zhao Y; Sun G; Zuo S; Chai J; Xu T; Liu J; Li L; Song J; Qian S; Kang Y; Sui F; Li M; Jia Q
Pathol Res Pract; 2022 Oct; 238():154090. PubMed ID: 36049441
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
Huang Y; Wu Q; Tan X
Bioengineered; 2022 Mar; 13(3):6955-6965. PubMed ID: 35249447
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
Lin Q; Jiang Y; Zhou F; Zhang Y
Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
10. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXD-AS1 affects proliferation and apoptosis of cervical cancer cells by promoting FRRS1 expression via transcription factor ELF1.
Liu H; Liu L; Liu Q; He F; Zhu H
Cell Cycle; 2022 Feb; 21(4):416-426. PubMed ID: 34985386
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.
He C; Liu L
Bioengineered; 2022 Apr; 13(4):8311-8322. PubMed ID: 35311456
[TBL] [Abstract][Full Text] [Related]
14. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
16. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
17. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
Dong Z; Chang X; Xie L; Wang Y; Hou Y
Bioengineered; 2022 Mar; 13(3):6100-6112. PubMed ID: 35192432
[TBL] [Abstract][Full Text] [Related]
19. The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways.
Gu YY; Yang M; Zhao M; Luo Q; Yang L; Peng H; Wang J; Huang SK; Zheng ZX; Yuan XH; Liu P; Huang CZ
Tumour Biol; 2015 Nov; 36(11):8379-87. PubMed ID: 26018507
[TBL] [Abstract][Full Text] [Related]
20. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]